Poly-Epitope Peptide Derived from Thymidylate Synthase Having Immunological and Anti-Tumour Activity
AssigneeUniversità Degli Studi Di Siena
InventorsPierpaolo Correale, Maria Grazia Cusi, Guido Francini, Giorgio Giorgi
Life of this patent
Estimating the term…
Abstract
The present invention concerns a peptide having anti-tumour activity and its related pharmaceutical compositions. In particular, the invention concerns a peptide with anti-tumour preventive and therapeutic activity, also in combination with other known anti-tumour compounds such as, for example, 5-fluorouracil.
Claims15
A peptide included in the sequence YMIAHITGLFLDSLGFSTTLGDAHIYL (Seq. Id. No. 2) for medical use.
A peptide having the sequence YMIAHITGLFLDSLGFSTTLGDAHIYL (Seq. Id. No. 2).
A vector including, and capable of efficaciously expressing in an eukaryote cell, a nucleotide sequence coding for the peptide according to one of the preceding claims.
A method for obtaining in vitro cytotoxic T lymphocytes (CTLs) activated for TS, including the following steps:
- a) take peripheral blood mononuclear cells (PBMCs) from a subject and culture them in vitro;
- b) stimulate in vitro said PBMCs by exposing them to irradiated autologous dendritic cells previously exposed for opportune time to efficacious concentrations of the peptide according to claims from 1 to 5.
Dependencies are inferred from the claim text.